Mannkind (MNKD) news
Recent news
Mannkind shares follow Uthr higher, up as much as 6.7%
AInvest Wire · Sep 30, 2026Mannkind Corporation: Specific financial terms of agreement were not disclosed
Mannkind Corporation has entered into a new agreement, the specific financial terms of which were not disclosed [1]. The company has not provided further details regarding the nature of the agreement or its potential impact on financial performance. Investors are advised to await additional…
AInvest Wire · Sep 9, 2026Mannkind Corporation - To provide development and manufacturing support through phase 1B in weight management study
AInvest Wire · Sep 9, 2026Mannkind Corporation - Rose Pharma receives exclusive worldwide license for Technosphere technology
MannKind Corporation (Nasdaq: MNKD) has entered into an exclusive licensing agreement with Rose Pharma, granting the latter Technosphere® inhalation technology rights . This partnership aligns with MannKind’s strategy of leveraging its proprietary drug delivery platform to collaborate with…
AInvest Wire · Sep 9, 2026Mannkind and Rose Pharma Inc enter licensing and collaboration agreement to develop an inhaled rapid-acting, short-duration GLP-1 for weight management
AInvest Wire · Sep 9, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.